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Laser Angioplasty: Unraveling the Gordian Knot* 
JEFFREY M. ISNER, MD, FACC, RICHARD H. CLARKE, PHD 
Boston. Massachusetts 
The concept of laser angioplasty owes its existence to the 
development of percutaneous transluminal balloon coronary 
angioplasty. Balloon angioplasty, like the mythical Athena, 
appeared to have been born nearly full grown: a series of 
canine experiments established the feasibility of this ap•
proach 0), after which Griintzig pioneered in a thoughtful 
and careful manner the first human applications in Europe. 
Within a short time, it was clear that this revolutionary 
therapy was both efficacious and safe (2). 
Laser coronary angioplasty represented the logical ex•
tension of the demonstration that a percutaneous, catheter•
based intervention could be used as definitive therapy for 
atherosclerotic lesions. Early work by Macruz (3), Lee (4), 
Abela (5) and Choy (6) and their coworkers convincingly 
demonstrated that laser radiation could vaporize atheroscle•
rotic plaque in vitro. Paradoxically, however, the same clin•
ical trials of balloon angioplasty that spurred these in vitro 
laser experiments constituted a liability of sorts: the apparent 
overnight success of balloon angioplasty created a false 
expectation that the time required for development of a 
clinically effective and safe laser coronary angioplasty sys•
tem would be similarly brief. When subsequent experience 
indicated that this would not be the case, much of the en•
thusiasm, indeed much of the credibility, of the concept of 
laser angioplasty was jeopardized. Yet it is unreasonable to 
expect that laser coronary angioplasty should be uniquely 
capable of defying a basic principle: there is a price to be 
paid for everything, and the greater the value, the higher 
the price. If laser coronary angioplasty in its ultimate form 
proves more widely applicable than balloon angioplasty, it 
is reasonable to expect that the price to be paid for this 
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development, both in terms of time and money, will be 
correspondingly greater. 
The Promise 
It is appropriate in this regard to examine what the cu•
mulative laboratory and clinical investigation of laser coro•
nary angioplasty has thus far wrought. First, and most im•
portant, it may be stated without equivocation that laser 
light, from the near ultraviolet to the far infrared, can pre•
dictably eliminate atherosclerotic plaque. This fact has been 
established and confirmed in vitro (3-11) and in vivo 
(7,8,12 -16), and represents the single most compelling rea•
son for pursuing the application of laser radiation for the 
treatment of coronary atherosclerosis. Bypass surgery lit•
erally bypasses the atherosclerotic lesion; not surprisingly, 
the long-term efficacy of this approach is imperfect (17,18). 
Balloon angioplasty remodels the atherosclerotic lesion (19); 
accordingly, recurrence of the lesion in an obstructive con•
figuration complicates 20% or more of such efforts (20). In 
contrast, laser-generated light categorically eliminates ath•
erosclerotic plaque, converting plaque from solid-phase matter 
to a water- (or blood-) soluble gas (21). While it may be 
argued that the surgeon's scalpel, too, can eliminate plaque 
(22), optical fibers make laser light, unlike the surgeon's 
scalpel, potentially transmissible through a percutaneously 
inserted guiding catheter. Thus the laser offers the promise 
of a percutaneous, definitive therapy for atherosclerosis. 
Why has the promise not been fulfilled? Basically be•
cause of a single, albeit megatherian, obstacle: failure to 
leave the vessel intact at the site of laser ablation. prelim•
inary work by Dwyer et al. (23) suggests that, as in ex•
perimental (24,25) and clinical (26) experience with balloon 
angioplasty, downstream release of particulate debris is un•
likely to complicate clinical application of laser angioplasty. 
Work by both Abela et al. (27) and Gerrity et al. (7) suggests 
that, at least in the short term, recurrence of atherosclerotic 
stenoses after laser angioplasty is unlikely. Perforation of 
the coronary artery wall underlying the target atherosclerotic 
lesion, however, currently represents the principal factor 
limiting routine clinical use of laser angioplasty in humans, 
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Figure 1. Components of generic laser angioplasty system. 
a fact that has been underscored by experience with simu•
lated intraoperative laser coronary angioplasty in human 
necropsy specimens (28), intraoperative laser coronary an•
gioplasty performed in conjunction with coronary artery 
bypass surgery (15) and peripheral laser angioplasty carried 
out in living persons (Robert Ginsberg, personal commu•
nication). 
Solving Perforation 
Efforts to eliminate the problem of vessel perforation 
have encompassed a variety of approaches, some realized, 
others under active investigation and still others only pro•
posed. These alternatives may be considered according to 
the individual components of the generic laser system il•
lustrated in Figure 1. 
The earliest attempts to deal with the problem of vessel 
perforation logically focused on alterations involving the 
catheter delivery system. Work by Lee (29), Choy (30) and 
their coworkers indicated that the optimal delivery system 
required a flexible, low profile, steerable, multi luminal de•
vice with a protective tip feature of some type, and possibly 
an intravascular imaging option as well. Sanborn et al. (16) 
reported an experimental decrease in vessel perforation us•
ing a metallic tip at the end of a quartz optical fiber; this 
so-called hot-tip uses argon laser light to accomplish a 
"thermal" angioplasty. Addition of a Doppler probe to the 
guiding catheter to detect high velocity flow near the sites 
of coronary stenoses has also been proposed (31) to identify 
the coronary lumen and thus maintain the guiding cathe•
ter/fiber optic coaxial with the coronary lumen. 
Perhaps the most innovative approach designed to obviate 
problems inherent in precise control of energy delivery at 
the distal tip of the guiding catheter/optical fiber involves 
administration of hematoporphyrin derivative to "stain" the 
atherosclerotic plaque. Spears et al. (32) have demonstrated 
that hematoporphyrin derivative, administered systemically, 
may be taken up by atherosclerotic plaque in experimental 
animal models; exposure of stained plaques to an appropriate 
wavelength of laser light might then be expected to induce 
atherolysis. The virtue of this approach is that it uses a 
diffusing tip (33), minimizing problems of catheter design 
required for precisely directed laser irradiation. 
More recent attempts to eliminate vessel wall perforation 
have involved evaluation of alternative laser sources to iden-
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tify those capable of vaporizing the pathologic lesion with•
out causing thermal injury to the underlying "normal tis•
sue" (for example, the arterial wall). Most biomedical 
applications of laser technology employed to date have used 
continuous wave lasers (34). Pathologic examination of car•
diovascular tissues irradiated with continuous wave lasers 
has consistently disclosed gross charring at the perimeter of 
the laser crater with distinctive light microscopic findings: 
a superficial zone of coagulation necrosis and a subjacent 
zone of polymorphous lacunae (3-9,21,35-37). These gross 
and histologic findings, interpreted to be the result of thermal 
injury, have not been observed when cardiovascular tissues 
are irradiated with pulsed ultraviolet light from an excimer 
laser (9-11). Furthermore, it is now clear that gross and 
light microscopic signs of thermal injury may be eliminated 
by pulsed energy delivery of any wavelength from the ul•
traviolet to the infrared, provided the peak power density 
is high enough and the repetition rate is low enough (38,39). 
Clinical application of pulsed energy delivery, however, 
will require modification of the remaining two components 
of the system illustrated in Figure 1. Development of a 
flexible, nontoxic, diminutive optical fiber that can with•
stand the peak powers characteristic of pulsed systems, as 
well as a means of coupling this output from the laser to 
the fiber, will be required. Preliminary work (10,40) sug•
gests that this is realistic; the recent demonstration that ex•
cimer emissions may be transmitted through a blood field 
(41) is likewise encouraging. 
The Cost 
As the preceding considerations imply, unraveling the 
Gordian knot of laser coronary angioplasty will be no trivial 
matter. The cost, both in money and time, promises to be 
substantial. On the other hand, the cost is principally up 
front. If laser coronary angioplasty could be suitably de•
veloped as a percutaneous alternative to bypass surgery, 
significant savings would accrue both to the patient in terms 
of decreased morbidity and to the economy in terms of 
reduced costs. Indeed, a recent analysis (42) revealed that 
for patients having balloon angioplasty rather than bypass 
surgery as an initial procedure for single vessel coronary 
disease, the total cost per patient was 43% lower for those 
having balloon angioplasty. 
Even if the technical difficulties involved in developing 
a percutaneous catheter delivery system were to limit laser 
coronary angioplasty to intraoperative application, the tech•
nique would still represent a major improvement in defin•
itive intervention for two groups of patients whose thera•
peutic options are now limited: those in whom coronary 
disease is too diffusely severe to allow consideration of 
bypass surgery, and those who have undergone extensive 
revascularization but now return with both a diffusely dis-
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eased native circulation and occluded or diffusely diseased 
bypass grafts, 
The unique capability of laser light to predictably expiate 
atherosclerotic plaque in vitro and in vivo mandates in•
vestment of appropriate resources to determine in a careful, 
thoughtful and systematic manner whether this technology 
can be translated into clinical reality, Given the resources 
available to the manned spacecraft program, it was recently 
possible to transmit a 6 mm argon laser beam 484 km from 
Mount Haleakala to a mirror on the spacecraft Discovery, 
orbiting at 39,600 km/h, and to accurately reflect the beam 
back to its source (43), Given substantially fewer resources 
than are currently committed to the exploration of outer 
space, it should be possible to direct laser light a distance 
of 80 cm in an efficacious yet controllable fashion, 
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